Skip to content
Screener

Long-Term Debt at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$5.05B+2.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$37.34B-4.8%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$35.09M+2.8%
Ardelyx logo
ArdelyxARDX
$251.82M+25.0%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$22.87M-1.0%
TTR
Turn Therapeutics Inc.TTRX
$5.94M

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemMarch 31,2026December 31,2025
Total current liabilities4,5304,180
Acquisition-related contingent consideration213254
Non-current portion of financial leases2023
Non-current portion of long-term debt19,87520,592
Deferred tax liabilities, net179147
Other non-current liabilities763793
Total liabilities25,58025,989
Commitments and contingencies (Note 17)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's long-term debt?
Bausch Health Companies (BHC) reported long-term debt of $19.88B in Q1 2026.
How has Bausch Health Companies's long-term debt changed year-over-year?
Bausch Health Companies's long-term debt decreased by 6.4% year-over-year, from $21.23B to $19.88B.
What is the long-term trend for Bausch Health Companies's long-term debt?
Over 5 years (2020 to 2025), Bausch Health Companies's long-term debt has grown at a -3.0% compound annual growth rate (CAGR), from $23.93B to $20.59B.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Ask your AI about Bausch Health Companies's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude